According to the predominance of VDR in non-parenchymal liver cells, activation of VDR in the liver has mainly anti-inflammatory and anti-fibrotic effects that may be beneficial in chronic cholestatic liver disease (such as PBC and PSC). The gene discussed is VDR; the disease is pancreatic serous cystadenoma.